inhibitors (lisinopril), and blood cholesterol-lowering statins (lovastatin) (ALL)-are independently capable of decreasing the risk of heart attack in individuals with diabetes or coronary artery disease.
1,2 KP's powerful biomathematical modeling program, Archimedes, then examined the effect of combining them. The results were impressive: the risk of heart attack and death would be immediately reduced by at least 71% for 650,000 KP members.
Jim Dudl, MD, (SCPMG) endocrinologist and clinical lead for the CMI diabetes workgroup, was a key force in initiating the Archimedes modeling and presenting the results to the CMI Board of Directors. As a result, clinical guidelines for the treatment of members with coronary artery disease (CAD) and diabetes mellitus (DM) were revised to include recommendations for treatment with ALL medications unless contraindicated or not tolerated.
To rapidly implement these life-saving recommendations, the ALL initiative was formed with Dr Dudl as clinical lead. "It's incredibly difficult to start these three medications in a population. Models of care help clinicians understand how to implement the initiative," he comments.
Regional programs reflect a variety of strategies for starting members at risk on ALL. "The regions are doing groundbreaking, innovative work," says Michelle Wong. New programs include mailed prescriptions, group visits, phone calls from pharmacists, electronic reminders for physicians, panel management tools and assistants, and getting the entire health care team involved. CMI provides quarterly ALL reports, allowing regions to evaluate their performance and identify successful strategies in other regions they can adopt.
In 
Getting Chronic Pain Under Control
Members with chronic pain represent 5.1% of the total membership, second only in prevalence to diabetes. This population can challenge primary care physicians for several reasons.
Functional impairment is frequent and marked. In a KP health-related quality of life study, individuals with chronic pain reported the most functional impairment and lowest quality of life of all chronic conditions; those who were employed missed an average of more than three days of work each month.
Utilization is high. Use of inpatient, outpatient, Emergency Department, and pharmacy services by members with chronic pain are all three to four times higher than for members of the same age and gender without it. And, until recently, information about effective management of chronic pain has often been hard for primary care providers to find.
Under the clinical leadership of Christine Whitten, MD, anesthesiologist and Clinical Coordinator for Pain Management (SCPMG), the chronic pain initiative focuses on improving health outcomes for KP members who live with discomfort. "Chronic pain results from nervous system changes after unrelieved intense or prolonged acute pain. A continuum of risk exists for chronic pain, with interventions at each level of risk that treat the patient and reduce the risk of progression to the next level," says Dr Whitten.
The benefits of more effectively managing chronic pain patients convinced CMI leadership the program was needed. A newly formed chronic pain workgroup moved quickly to identify champions at medical centers and create the fundamentals of the care management program, which relies on primary care providers to assess, treat, and refer members at risk for and suffering from chronic pain.
"We view ourselves as support for primary care providers," says Dr Whitten. Drawing on work from the regions, including Northwest Permanente, The Permanente Medical Group, and Southern California Permanente Medical Group, the workgroup created pain management guidelines and developed a model of care including primary and specialty Hospital admissions decreased, but the average length of stay (ALOS) increased significantly for chronic painrelated stays. Emergency Department visits also increased. Costs attributable to the increased ALOS offset cost savings from decreased outpatient and pharmacy utilization, raising the overall costs of caring for this population. Further study is needed to understand the cause of the increased length of stay and possible improvement opportunities.
In 2005, the chronic pain workgroup is supporting rapid cycle improvement projects in three areas: medication management, utilization, and clinician-to-clinician communication. Four to eight projects in each of these areas will generate new information about how best to manage chronic pain and help KP members thrive.
Spreading High Performance Around
A recent CMI research project examined consistent differences between regional performance on outcomes measures for diabetes care. The goal of the Improving Performance Project was to identify statistically significant links between care practices and better regional performance. "Only a few organizations attempt to connect population care management practices with clinical performance," says Beth Branthaver.
The project gathered data on 20 diabetes care prac- Five care practices were most closely associated with better performance: electronic health records, assessing patient needs and incorporating them into personalized action plans, patient disease registries, and reaching out to patients to bring them in for care and to follow up afterward. With the advent of KP HealthConnect, CMI has focused on the latter three, helping regions to understand their key elements and to put them into place. ❖
